Understanding how SF3B1 mutations affect blood cell development in myelodysplastic syndromes.
Charting the differentiation topology of SF3B1 mutated clonal hematopoiesis (CH) and myelodysplastic syndromes (MDS) via a multi-omics single-cell toolkit
This study is looking at how changes in a specific gene (SF3B1) affect blood cell production in people with myelodysplastic syndromes (MDS), using advanced techniques to understand these changes at the single-cell level, which could help improve treatments for the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11014391 on NIH RePORTER |
What this research studies
This research investigates the impact of SF3B1 mutations on blood cell formation in patients with myelodysplastic syndromes (MDS). By utilizing advanced single-cell genomic techniques, the study aims to analyze how these mutations influence gene expression and cellular behavior in blood progenitor cells. The approach involves examining individual cells to capture a detailed picture of genetic alterations and their effects on blood cell differentiation. This could lead to a better understanding of the disease and potential new treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with myelodysplastic syndromes who have SF3B1 mutations.
Not a fit: Patients without myelodysplastic syndromes or those who do not have SF3B1 mutations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic and therapeutic options for patients with myelodysplastic syndromes.
How similar studies have performed: Other research has shown promising results using single-cell genomic approaches to understand complex blood disorders, indicating that this methodology is both relevant and potentially impactful.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Landau, Dan — Weill Medical Coll of Cornell Univ
- Study coordinator: Landau, Dan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.